"After testing the effect of the drug WIN55.212-2, which interacts with cannabinoid receptors, on rodents in the early stages of the disease, the team found “that they behaved in the same way as those without brain damage: they learned and remembered spatial orientation in the same way,” explained Marta Moreno. “You could say that in some way the drug reversed the damage or protected the brain.”"
No comments:
Post a Comment